Junqi Q. He
Beijing, 100006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Chemoradiotherapy facilitates siglec-10+/siglec-9+ macrophage-mediated impairment of CD24+/MUC16+ tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 23, 2025
TEMPORARY REMOVAL: PDZK1 disassembles HER2-HSP90 complexes to promote ubiquitin-mediated HER2 degradation and overcome therapy resistance.
Journal: Journal of advanced research
Published: August 05, 2025
MAGI3 deficiency unleashes β-catenin conformational change to drive metastatic progression and mTOR inhibitor resistance in ccRCC.
Journal: Cell death & disease
Published: July 22, 2025
PDZK1-ULK1 Axis Triggers Lipophagy to Inhibit Tumor Progression and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 23, 2025
Author Correction: A targetable OSGIN1-AMPK-SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis.
Journal: NPJ precision oncology
Published: February 28, 2025
Comparative analysis of AI models in disseminating genetic counseling knowledge for gynecologic cancers.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: February 18, 2025
The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer.
Journal: Frontiers in medicine
Published: December 03, 2024
MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker.
Journal: Cell death & disease
Published: July 23, 2024
Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD).
Journal: Scientific reports
Published: June 25, 2024
PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway.
Journal: British journal of cancer
Published: September 11, 2023
Last Updated: 09/26/2026